% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • rockystar996 rockystar996 Jul 3, 2013 1:38 PM Flag

    Real potential of omonty and takeda knows what they have it read this only in japan 1 billion dollor

    In a statement, Arlene Morris, president and CEO of Palo Alto, CA-based Affymax, said Takeda is an ideal partner because of its development experience and commercial capabilities. “Takeda has already shown its commitment to Hematide with the rapid filing of an investigational new drug application in Japan,” she said, “and we believe will bring a similar dedication to the development of Hematide globally.” Hematide

0.0843-0.0010(-1.23%)Feb 8 10:27 AMEST